Cash Rich Novavax Has Upside Potential
Value Insight - at Seeking Alpha - Tue Dec 23, 12:44PM CST
NVAX: 5.81 (+0.18)
Novavax Shares Up 29.2% Since SmarTrend's Buy Recommendation (NVAX)
Comtex SmarTrend(R) - Tue Dec 23, 9:18AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 7 months, Novavax has returned 29.22% as of today's recent price of $5.86.
NVAX: 5.81 (+0.18)
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris
PR Newswire - Wed Dec 17, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: Celgene Corporation (NASDAQ: CELG), Novavax Inc. (NASDAQ: NVAX), Amarin Corporation PLC (NASDAQ: AMRN), Immunomedics Inc. (NASDAQ: IMMU), and Aeterna Zentaris Inc. (NASDAQ: AEZS). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, December 16, 2014, the NASDAQ Composite ended at 4,547.83, down 1.24%, the Dow Jones Industrial Average declined 0.65%, to finish the day at 17,068.87, and the S&P 500 closed at 1,972.74, down 0.85%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 776.88, down 1.27%, while the index has advanced 4.39% in the previous three months. Register for your complimentary reports on these five stocks at:
IMMU: 4.41 (+0.13), NVAX: 5.81 (+0.18), AMRN: 0.99 (unch), AEZS: 0.59 (-0.02), CELG: 109.60 (+3.48), CELGZ: 3.34 (-0.01)
Shares of NVAX Up 24.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 15, 4:48PM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 7 months, Novavax has returned 24.15% as of today's recent price of $5.63.
NVAX: 5.81 (+0.18)
Is Novavax Really Worth 25 Times As Much As Vical?
Intrepid Investor - at Seeking Alpha - Mon Dec 15, 11:08AM CST
VICL: 1.03 (+0.02), NVAX: 5.81 (+0.18)
Unveiled House Spending Bill Bullish For Ebola Stocks
Matthew Finston - at Seeking Alpha - Wed Dec 10, 8:46AM CST
NVAX: 5.81 (+0.18), NLNK: 39.08 (+1.36), OSUR: 10.26 (+0.25)
Novavax: Expect Chain Reaction In Stock Price From Multiple Catalytic Events
Michael Slattery - at Seeking Alpha - Wed Dec 10, 7:08AM CST
NVAX: 5.81 (+0.18)
Uptrend Call Working As Novavax Stock Rises 16.0% (NVAX)
Comtex SmarTrend(R) - Mon Dec 01, 9:55AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 7 months, Novavax has returned 15.99% as of today's recent price of $5.26.
NVAX: 5.81 (+0.18)
Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference
Thomson Reuters ONE - Wed Nov 26, 7:33AM CST
GAITHERSBURG, Md., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the 26th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2014 at 11:00 a.m. ET in New York, NY at The New York Palace Hotel.
NVAX: 5.81 (+0.18)
InsiderInsights.com Daily Round Up 11/21/14: OPK, AVID, PAH, JCP
InsiderInsights - at Seeking Alpha - Mon Nov 24, 2:11PM CST
STFC: 23.53 (+0.43), EYES: 11.01 (+0.86), CMLP: 15.30 (+0.04), SEE: 43.40 (+0.42), DDD: 30.54 (-0.64), BBY: 38.89 (-0.80), MRD: 18.64 (-0.53), PAH: 23.00 (+0.01), RL: 184.35 (+0.70), AVID: 14.36 (+0.26), OPK: 9.63 (+0.21), LRE: 7.00 (-0.20), NVAX: 5.81 (+0.18), JCP: 6.50 (-0.24), AINC: 89.50 (+2.50), SYRG: 12.97 (-0.04), SFXE: 4.42 (+0.04)
Novavax Has Returned 13.1% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Mon Nov 24, 10:15AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 6 months, Novavax has returned 13.12% as of today's recent price of $5.13.
NVAX: 5.81 (+0.18)
Novavax Earnings In Retrospect: Down 0.6% in the Last 19 Days (NVAX)
Comtex SmarTrend(R) - Mon Nov 24, 9:43AM CST
Two weeks ago on November 5th, 2014 Novavax (NASDAQ:NVAX) reported earnings and analysts, on average, expected a loss of $0.07 on sales of $9.4 million. Novavax actually reported a loss of $0.08 per share on sales of $8.2 million, missing EPS estimates by $0.01 and missing revenue estimates by $1.2 million. Since the company's report, shares of Novavax have fallen from $5.13 to $5.10, representing a loss of 0.6% in the past 19 days.
NVAX: 5.81 (+0.18)
Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 5:45PM CST
Novavax (NVAX) was granted fast track status in the U.S. for its experimental RSV F vaccine for the protection of infants via maternal immunization.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), NVAX: 5.81 (+0.18), AMAG: 43.02 (+0.90)
Best Buy and Activision are big market movers
AP - Thu Nov 20, 3:27PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 17.82 (-0.01), VIPS: 19.95 (+0.41), CLV: 5.53 (-0.10), KIRK: 23.38 (+0.14), BBY: 38.89 (-0.80), CLF: 6.06 (-0.09), WSM: 75.32 (-0.61), CZR: 15.44 (+0.20), DISH: 72.63 (+0.54), ATVI: 20.35 (+0.12), NVAX: 5.81 (+0.18), TGT: 74.65 (-0.04), AGIO: 109.67 (+2.45), OPLK: 24.23 (-0.03), CRM: 60.33 (-0.17)
Novavax RSV vaccine candidate Fast Track'd
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 9:34AM CST
NVAX: 5.81 (+0.18)
U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization
GlobeNewswire - Thu Nov 20, 9:12AM CST
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization.
NVAX: 5.81 (+0.18)
InsiderInsights.com Daily Round Up 11/18/14: NES, TTS, RCAP, GSAT
InsiderInsights - at Seeking Alpha - Wed Nov 19, 3:29AM CST
CLUB: 5.90 (-0.07), MLM: 111.69 (-0.10), NES: 4.96 (-0.44), VOYA: 43.00 (+0.09), THG: 71.98 (+0.36), RXN: 28.18 (+0.06), GSAT: 2.97 (+0.03), LKFN: 42.45 (+0.31), PCLN: 1,149.78 (+2.17), TTS: 8.87 (+0.04), RCAP: 11.23 (+0.26), SPW: 86.64 (-0.11), NVAX: 5.81 (+0.18), WRLD: 79.98 (+0.15), TRUE: 23.50 (+0.31), BLMN: 23.79 (+0.18), BRX: 24.90 (-0.32), CMCSA: 58.07 (+0.17), SCHW: 30.67 (+0.01)